Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
File(s)grace score paper accepted.docx (78.19 KB) Heart-2016-Rothnie-heartjnl-2016-309359.pdf (389.23 KB)
Accepted version
Published version
Author(s)
Type
Journal Article
Abstract
Objective
To assess the accuracy of Global Registry of Acute Coronary Events (GRACE) scores in predicting mortality at 6 months for people with COPD and to investigate how it might be improved.
Methods
Data were obtained on 481,849 patients with acute coronary syndrome (ACS) admitted to UK hospitals between January 2003-June 2013 from the myocardial ischaemia national audit project (MINAP) database. We compared risk of death between chronic obstructive pulmonary disease (COPD) and non-COPD patients at 6 months, adjusting for predicted risk of death. We then assessed whether several modifications improved the accuracy of the GRACE score for people with COPD.
Results
The risk of death after adjusting for GRACE score predicted risk of death was higher for COPD patients than for other patients (RR 1.29, 95% CI 1.28-1.33). Adding smoking into the GRACE score model did not improve accuracy for COPD patients. Either adding COPD into the model (RR 1.00, 0.94-1.02) or multiplying the GRACE score by 1.3 resulted in better performance (RR 0.99, 0.96-1.01).
Conclusion
GRACE scores underestimate risk of death for people with COPD. A more accurate prediction of risk of death can be obtained by adding COPD into the GRACE score equation, or by multiplying the GRACE score predicted risk of death by 1.3 for people with COPD. This means that one third of COPD patients currently classified as low risk should be classified as moderate risk, and could be considered for more aggressive early treatment after non-ST-elevation myocardial infarction or unstable angina.
To assess the accuracy of Global Registry of Acute Coronary Events (GRACE) scores in predicting mortality at 6 months for people with COPD and to investigate how it might be improved.
Methods
Data were obtained on 481,849 patients with acute coronary syndrome (ACS) admitted to UK hospitals between January 2003-June 2013 from the myocardial ischaemia national audit project (MINAP) database. We compared risk of death between chronic obstructive pulmonary disease (COPD) and non-COPD patients at 6 months, adjusting for predicted risk of death. We then assessed whether several modifications improved the accuracy of the GRACE score for people with COPD.
Results
The risk of death after adjusting for GRACE score predicted risk of death was higher for COPD patients than for other patients (RR 1.29, 95% CI 1.28-1.33). Adding smoking into the GRACE score model did not improve accuracy for COPD patients. Either adding COPD into the model (RR 1.00, 0.94-1.02) or multiplying the GRACE score by 1.3 resulted in better performance (RR 0.99, 0.96-1.01).
Conclusion
GRACE scores underestimate risk of death for people with COPD. A more accurate prediction of risk of death can be obtained by adding COPD into the GRACE score equation, or by multiplying the GRACE score predicted risk of death by 1.3 for people with COPD. This means that one third of COPD patients currently classified as low risk should be classified as moderate risk, and could be considered for more aggressive early treatment after non-ST-elevation myocardial infarction or unstable angina.
Date Issued
2016-05-13
Date Acceptance
2016-04-22
Citation
Heart, 2016, 102, pp.1442-1448
ISSN
1468-201X
Publisher
BMJ Publishing Group
Start Page
1442
End Page
1448
Journal / Book Title
Heart
Volume
102
Copyright Statement
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
License URL
Sponsor
GlaxoSmithKline Services Unlimited
Grant Number
PO #3000555261
Subjects
Cardiovascular System & Hematology
1102 Cardiovascular Medicine And Haematology
Publication Status
Published